Canon Medical Systems recently introduced AiCE (Advanced intelligent Clear IQ Engine), a deep convolutional neural network (DCNN) image reconstruction technology for computed tomography (CT). AiCE uses deep learning technology to differentiate signal from noise so that it removes noise while it preserves true signal.

February 27, 2019 — Radiologists quickly learn to read 3-D mammography more accurately than they read standard 2-D ...

The U.S. Food and Drug Administration (FDA) issued a warning letter to Total Thermal Imaging Inc., of La Mesa, Calif., and its president and co-owner, Linda Hayes, for illegally marketing and distributing an unapproved thermography device as a sole screening device for breast cancer and other diseases. The FDA also issued a safety communication to warn patients that thermography is not cleared by the FDA as an alternative to mammography and should not replace mammography for breast cancer screening or diagnosis.

GE Healthcare announced Feb. 25 the sale of its biopharmaceutical business to Danaher, and GE Chairman and CEO Larry Culp Jr. said the deal signified that a planned 2019 initial public offering (IPO) for GE Healthcare is now unlikely. GE is reportedly weighing its options following the deal, which casts off the biopharmaceutical business for $21.4 billion.